Canon kabushiki kaisha (20240093087). POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST simplified abstract
Contents
- 1 POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
Organization Name
Inventor(s)
NORISHIGE Kakegawa of Tokyo (JP)
TAKAHIRO Masumura of Tochigi (JP)
TEIGO Sakakibara of Tokyo (JP)
FUMIO Yamauchi of Kanagawa (JP)
KENGO Kanazaki of Kanagawa (JP)
POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240093087 titled 'POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
Simplified Explanation
The patent application describes a particle with high detection sensitivity for measuring substances such as antigens or antibodies in the body. The particle contains a rare earth complex, has a small particle size distribution, and a hydrophilic polymer on its surface.
- The particle has high detection sensitivity for measuring substances in the body.
- Contains a rare earth complex.
- Small particle size distribution with a hydrophilic polymer on its surface.
Potential Applications
This technology could be used in various medical applications such as diagnostic tests, drug delivery systems, and targeted therapy.
Problems Solved
This technology solves the problem of accurately detecting and measuring specific substances in the body with high sensitivity and precision.
Benefits
The benefits of this technology include improved accuracy in measuring substances, early detection of diseases, and targeted delivery of drugs.
Potential Commercial Applications
One potential commercial application of this technology could be in the development of advanced diagnostic kits for healthcare providers.
Possible Prior Art
One possible prior art could be the use of nanoparticles for targeted drug delivery systems in medical applications.
Unanswered Questions
How does this technology compare to existing detection methods in terms of sensitivity and accuracy?
This article does not provide a direct comparison with existing detection methods in terms of sensitivity and accuracy. Further research or testing may be needed to determine the superiority of this technology over existing methods.
What is the cost-effectiveness of implementing this technology in medical settings?
The article does not address the cost-effectiveness of implementing this technology in medical settings. A cost-benefit analysis would be necessary to evaluate the economic feasibility of using this technology in healthcare.
Original Abstract Submitted
provided is a particle having high detection sensitivity in the detection of a substance to be measured, such as an antigen or an antibody, from a body. the particle includes a rare earth complex, wherein the particle has a particle size distribution of 0.1 or less in terms of polydispersity index (pdi) measured by dynamic light scattering, and wherein the particle has a hydrophilic polymer on a surface thereof.
